Latest news
Divesiran Eliminates Need for Phlebotomy in 88% of Patients With Polycythemia Vera - Cure TodayCure Today · Mon, 10 Aug 2026 20:53:09 GMTSilence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile - Business WireBusiness Wire · Mon, 10 Aug 2026 11:30:00 GMTReal-World Polycythemia Care Often Fails to Control Hematocrit - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Thu, 06 Aug 2026 17:55:08 GMT